Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on Invested CapitalReturn on Sales

Dr Reddys Laboratories (RDY) Return on Equity (2016 - 2023)

Historic Return on Equity for Dr Reddys Laboratories (RDY) over the last 14 years, with Q3 2023 value amounting to 0.42%.

  • Dr Reddys Laboratories' Return on Equity changed N/A to 0.42% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.42%, marking a year-over-year change of. This contributed to the annual value of 0.18% for FY2025, which is 300.0% down from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Return on Equity of 0.42% as of Q3 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Return on Equity peaked at 0.42% during Q3 2023, and registered a low of 0.11% during Q4 2020.
  • In the last 5 years, Dr Reddys Laboratories' Return on Equity had a median value of 0.28% in 2020 and averaged 0.26%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -308400bps in 2019, then tumbled by -200bps in 2020.
  • Over the past 5 years, Dr Reddys Laboratories' Return on Equity (Quarter) stood at 0.13% in 2019, then decreased by -13bps to 0.11% in 2020, then surged by 95bps to 0.22% in 2021, then soared by 48bps to 0.33% in 2022, then rose by 29bps to 0.42% in 2023.
  • Its Return on Equity stands at 0.42% for Q3 2023, versus 0.31% for Q2 2023 and 0.33% for Q2 2022.